Clinic Disease Nuclear Medicine 
AuntMinnie
MARCH 13, 2025
F-18 fluoroestradiol (FES)-PET scans can predict whether or not endocrine therapy may be effective in women with estrogen receptor (ER)-positive breast cancer, according to a study published March 13 in the Journal of Nuclear Medicine. Image courtesy of the Journal of Nuclear Medicine. A visual abstract of the analysis.
AuntMinnie
FEBRUARY 28, 2025
The finding is from a preliminary analysis of 23 patients enrolled in an ongoing clinical trial, noted Giorgio Brembilla, MD, PhD, of the IRCCS San Raffaele Scientific Institute in Milan, Italy. The trial will eventually enroll 167 undiagnosed patients with suspected disease who have been referred for biopsies, Brembilla noted.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
AuntMinnie
MARCH 4, 2025
Preliminary studies suggest the tracer may also be effective in patients with earlier, more treatable stages of the disease, yet most of these studies have been retrospective and subject to a large risk of bias, the authors noted. The full study is available here.
AuntMinnie
MARCH 15, 2024
The recommendations could improve patient care, as current clinical tools are often insufficient in complicated cases, noted lead author of the guidance Jamieson Bourque, MD, of the University of Virginia Health System in Charlottesville. The recommendations emphasize the complementary nature of these advanced nuclear medicine exams.
AuntMinnie
FEBRUARY 14, 2025
The study was published February 13 in the Journal of Nuclear Medicine. Image courtesy of the Journal of Nuclear Medicine. Thus, with further development in larger trials, Ga-68 FZ-NR-1 could play a significant clinical role, they suggested. The full study is available here.
AuntMinnie
OCTOBER 27, 2023
Patients with less tau pathology on PET scans may respond better to treatment with the new Alzheimer’s disease drug donanemab, according to an October 25 news report in the journal Practical Neurology. Research suggests that the accumulation of these proteins is a continuous process that starts decades before the onset of symptoms.
AuntMinnie
APRIL 29, 2024
PET brain scans show persistent brain inflammation in patients with multiple sclerosis (MS), despite being treated with high-efficacy disease-modifying therapies, according to a recent study by researchers in Boston. Image courtesy of Clinical Nuclear Medicine. The full article is available here.
Expert insights. Personalized for you.
227 
Let's personalize your content